Pamrevlumab
Drug timelines are a Plus or Pro feature.
10 regulatory and trial events tracked for Pamrevlumab, covering 2016-08-16 to 2024-11-05. Get the full timeline:
Most recent: Clinical Trial Update: Evaluation of Efficacy and Safety of Neoadjuvant Treatment With Pamrevlumab in Combination With Chemotherapy (Either Gemcitabine Plus Nab-paclitaxel or FOLFIRINOX) in Participants With Locally Advanced, Unresectable Pancreatic Cancer [Phase 3]